This is a news story, published by ScienceDaily, that relates primarily to Cancer Discovery news.
For more Cancer Discovery news, you can click here:
more Cancer Discovery newsFor more biology news, you can click here:
more biology newsFor more news from ScienceDaily, you can click here:
more news from ScienceDailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
ovarian cancer chemotherapy. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest ovarian cancer patients news, ovarian cancers news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Iron Chelation Therapy Elicits Innate Immune ControlScienceDaily
•79% Informative
Preclinical study explores approved drug for ovarian cancer.
Iron-binding drug called deferiprone could provide novel way to attack ovarian tumors.
The preclinical study combined analysis of human ovarian tumors and animal models of the disease.
The study was published in Cancer Discovery , a journal of the American Association for Cancer Research .
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer.
Cancer Discovery , 2024 ; DOI: 10.1158/2159/8290.CD-23-1451 Cite This Page: - Tito A. Sandoval, Camilla Salvagno .
VR Score
87
Informative language
93
Neutral language
56
Article tone
formal
Language
English
Language complexity
78
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links